U.S. flag

An official website of the United States government

NM_003597.5(KLF11):c.1039G>T (p.Ala347Ser) AND Maturity-onset diabetes of the young type 7

Germline classification:
Uncertain significance (2 submissions)
Last evaluated:
May 22, 2022
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000006871.4

Allele description [Variation Report for NM_003597.5(KLF11):c.1039G>T (p.Ala347Ser)]

NM_003597.5(KLF11):c.1039G>T (p.Ala347Ser)

Gene:
KLF11:KLF transcription factor 11 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
2p25.1
Genomic location:
Preferred name:
NM_003597.5(KLF11):c.1039G>T (p.Ala347Ser)
Other names:
A349S
HGVS:
  • NC_000002.12:g.10048376G>T
  • NG_017199.1:g.9822G>T
  • NM_001177716.2:c.988G>T
  • NM_001177718.2:c.988G>T
  • NM_003597.5:c.1039G>TMANE SELECT
  • NP_001171187.1:p.Ala330Ser
  • NP_001171189.1:p.Ala330Ser
  • NP_003588.1:p.Ala347Ser
  • NC_000002.11:g.10188503G>T
  • O14901:p.Ala347Ser
Protein change:
A330S; ALA349SER
Links:
UniProtKB: O14901#VAR_031524; OMIM: 603301.0001; dbSNP: rs121912645
NCBI 1000 Genomes Browser:
rs121912645
Molecular consequence:
  • NM_001177716.2:c.988G>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001177718.2:c.988G>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_003597.5:c.1039G>T - missense variant - [Sequence Ontology: SO:0001583]
Observations:
1

Condition(s)

Name:
Maturity-onset diabetes of the young type 7 (MODY7)
Synonyms:
MODY type 7; Diabetes mellitus MODY type 7; MODY KLF11 related
Identifiers:
MONDO: MONDO:0012513; MedGen: C1864839; Orphanet: 552; OMIM: 610508

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000027067OMIM
no assertion criteria provided
Pathogenic
(Mar 29, 2005)
germlineliterature only

PubMed (1)
[See all records that cite this PMID]

SCV0025214183billion
criteria provided, single submitter

(ACMG Guidelines, 2015)
Uncertain significance
(May 22, 2022)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyes1not providednot provided1not providedclinical testing
not providedgermlinenot providednot providednot providednot providednot providednot providedliterature only

Citations

PubMed

Role of transcription factor KLF11 and its diabetes-associated gene variants in pancreatic beta cell function.

Neve B, Fernandez-Zapico ME, Ashkenazi-Katalan V, Dina C, Hamid YH, Joly E, Vaillant E, Benmezroua Y, Durand E, Bakaher N, Delannoy V, Vaxillaire M, Cook T, Dallinga-Thie GM, Jansen H, Charles MA, Clément K, Galan P, Hercberg S, Helbecque N, Charpentier G, Prentki M, et al.

Proc Natl Acad Sci U S A. 2005 Mar 29;102(13):4807-12. Epub 2005 Mar 17.

PubMed [citation]
PMID:
15774581
PMCID:
PMC554843

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL; ACMG Laboratory Quality Assurance Committee..

Genet Med. 2015 May;17(5):405-24. doi: 10.1038/gim.2015.30. Epub 2015 Mar 5.

PubMed [citation]
PMID:
25741868
PMCID:
PMC4544753

Details of each submission

From OMIM, SCV000027067.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedliterature only PubMed (1)

Description

In affected members of a 4-generation family with MODY-like diabetes (MODY7; 610508), Neve et al. (2005) identified heterozygosity for a 1039G-T transversion in exon 3 of the KLF11 gene, resulting in an ala349-to-ser (A349S) substitution in the third repressor domain. The variant segregated with diabetes and glucose intolerance in all 3 generations examined and was not found in 313 patients with late-onset type II diabetes or in 313 normoglycemic individuals. Bioinformatics analysis predicted that the variant would alter the secondary protein structure of the repressor domain.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlinenot providednot providednot providednot providednot providednot providednot providednot provided

From 3billion, SCV002521418.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided1not providednot providedclinical testing PubMed (1)

Description

The variant is observed at an allele frequency greater than expected (0.01%) for the associated disorder in the gnomAD v2.1.1 dataset and therefore considered uncertain significant. Functional studies provide strong evidence of the variant having a damaging effect on the gene or gene product (PMID: 15774581). In silico tool predictions suggest no damaging effect of the variant on gene or gene product (REVEL: 0.18; 3Cnet: 0.00). Same nucleotide change resulting in same amino acid change has been previously reported to be associated with KLF11 related disorder (ClinVar ID: VCV000006498 / PMID: 15774581). However, the evidence of pathogenicity is insufficient at this time. Therefore, this variant is classified as uncertain significance according to the recommendation of ACMG/AMP guideline.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyes1not providednot provided1not providednot providednot provided

Last Updated: Sep 29, 2024